195 related articles for article (PubMed ID: 24345005)
21. Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.
Moore H; Romeril K
Intern Med J; 2011 Apr; 41(4):348-50. PubMed ID: 21507163
[TBL] [Abstract][Full Text] [Related]
22. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
Jayabose S; Dunbar J; Nowicki TS; Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of autoantibody repertoire is needed in thrombotic thrombocytopenia purpura.
Scally B; Loan J
Thromb Res; 2013 Sep; 132(3):e165. PubMed ID: 23768450
[No Abstract] [Full Text] [Related]
24. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
[TBL] [Abstract][Full Text] [Related]
25. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
[No Abstract] [Full Text] [Related]
26. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory anti-ADAMTS 13 antibodies: measurement and clinical application.
Scully M
Blood Rev; 2010 Jan; 24(1):11-6. PubMed ID: 19963308
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Cataland SR; Jin M; Ferketich AK; Kennedy MS; Kraut EH; George JN; Wu HM
Br J Haematol; 2007 Jan; 136(1):146-9. PubMed ID: 17069579
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sjögren's syndrome: two cases and a literature review.
Yamashita H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2013 Mar; 23(2):365-73. PubMed ID: 22526830
[TBL] [Abstract][Full Text] [Related]
30. Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
Herbei L; Venugopal P
Clin Adv Hematol Oncol; 2006 Mar; 4(3):215-7; discussion 217-8. PubMed ID: 16728931
[No Abstract] [Full Text] [Related]
31. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community.
George JN; Vesely SK
Ann Intern Med; 2003 Jan; 138(2):152-3. PubMed ID: 12529099
[No Abstract] [Full Text] [Related]
32. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
[TBL] [Abstract][Full Text] [Related]
33. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: III. Diagnosis and treatment; 4. Thrombotic thrombocytopenic purpura].
Matsumoto M
Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1613-21. PubMed ID: 25154256
[No Abstract] [Full Text] [Related]
34. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
[TBL] [Abstract][Full Text] [Related]
36. Improving on nature: redesigning ADAMTS13.
Kremer Hovinga JA; Voorberg J
Blood; 2012 Apr; 119(16):3654-5. PubMed ID: 22517874
[No Abstract] [Full Text] [Related]
37. Thrombotic thrombocytopenic purpura associated with statin therapy.
Thomas MR; McDonald V; Machin SJ; Scully MA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):762-3. PubMed ID: 22198366
[No Abstract] [Full Text] [Related]
38. Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.
Watanaboonyongcharoen P; Whinna HC; Park YA
J Clin Apher; 2014 Dec; 29(6):336-8. PubMed ID: 24764259
[TBL] [Abstract][Full Text] [Related]
39. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R
Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
